# Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.

> **NCT02242123** · — · COMPLETED · sponsor: **University of Palermo** · enrollment: 50 (actual)

## Conditions studied

- Celiac Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02242123
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-12
- **Final completion:** 2020-06-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242123, "Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02242123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*